A Review of Bisphosphonate-Associated Osteonecrosis of the Jaws and Its Management
• David K. Lam, DDS •
• George K.B. Sándor, MD, DDS, PhD, FRCD(C), FRCSC, FACS •
• Howard I. Holmes, DDS •
• A. Wayne Evans, M.D. •
• Cameron M.L. Clokie, DDS, PhD, FRCD(C) •
View the complementary PowerPoint presentation
narrated by Dr. George K.B. Sándor.
A b s t r a c t
Bisphosphonate-associated osteonecrosis (BON) may result in serious oral complications, such as osteomyelitis and chronic exposure of necrotic bone. Dentists must be familiar with this disorder and pay special attention to all patients on bisphosphonate therapy due to their defective osteoclast function and reduced osseous tissue vascularity, leading to impaired wound healing. The purpose of this paper is to review the history and pathogenesis of BON, discuss its differential diagnosis, provide guidance to dentists on possible measures to prevent BON and review the management of patients with BON.
Reply to this article | View replies